225 related articles for article (PubMed ID: 37080995)
1. RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.
Chen L; Zhang W; Chen D; Yang Q; Sun S; Dai Z; Li Z; Liang X; Chen C; Jiao Y; Zhi L; Zhao L; Zhang J; Liu X; Zhao J; Li M; Wang Y; Qi Y
Signal Transduct Target Ther; 2023 Apr; 8(1):159. PubMed ID: 37080995
[TBL] [Abstract][Full Text] [Related]
2. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells.
Zu Y; Liu L; Lee MY; Xu C; Liang Y; Man RY; Vanhoutte PM; Wang Y
Circ Res; 2010 Apr; 106(8):1384-93. PubMed ID: 20203304
[TBL] [Abstract][Full Text] [Related]
3. Circ_0001093 promotes glutamine metabolism and cancer progression of esophageal squamous cell carcinoma by targeting miR-579-3p/glutaminase axis.
Qian CJ; Tong YY; Wang YC; Teng XS; Yao J
J Bioenerg Biomembr; 2022 Apr; 54(2):119-134. PubMed ID: 35322289
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
5. RBM4 regulates cellular senescence via miR1244/SERPINE1 axis.
Wang L; Zhang X; Sheng J; Chen L; Zhi L; Zheng Q; Qi Y; Wang L; Zhang J; Zhao J; Wang Y; Liu SX; Sun MZ; Zhang W
Cell Death Dis; 2023 Jan; 14(1):27. PubMed ID: 36639375
[TBL] [Abstract][Full Text] [Related]
6. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
Hawley SA; Boudeau J; Reid JL; Mustard KJ; Udd L; Mäkelä TP; Alessi DR; Hardie DG
J Biol; 2003; 2(4):28. PubMed ID: 14511394
[TBL] [Abstract][Full Text] [Related]
7. Midkine noncanonically suppresses AMPK activation through disrupting the LKB1-STRAD-Mo25 complex.
Xia T; Chen D; Liu X; Qi H; Wang W; Chen H; Ling T; Otkur W; Zhang CS; Kim J; Lin SC; Piao HL
Cell Death Dis; 2022 Apr; 13(4):414. PubMed ID: 35487917
[TBL] [Abstract][Full Text] [Related]
8. Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling.
Li N; Wang Y; Neri S; Zhen Y; Fong LWR; Qiao Y; Li X; Chen Z; Stephan C; Deng W; Ye R; Jiang W; Zhang S; Yu Y; Hung MC; Chen J; Lin SH
Nat Commun; 2019 Sep; 10(1):4363. PubMed ID: 31554794
[TBL] [Abstract][Full Text] [Related]
9. Genistein-induced LKB1-AMPK activation inhibits senescence of VSMC through autophagy induction.
Lee KY; Kim JR; Choi HC
Vascul Pharmacol; 2016 Jun; 81():75-82. PubMed ID: 26924458
[TBL] [Abstract][Full Text] [Related]
10. NEDD4L inhibits cell viability, cell cycle progression, and glutamine metabolism in esophageal squamous cell carcinoma via ubiquitination of c-Myc.
Cheng W; Li G; Ye Z; Hu J; Gao L; Jia X; Zhao S; Wang Y; Zhou Q
Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(5):716-724. PubMed ID: 35593463
[TBL] [Abstract][Full Text] [Related]
11. Skp2-dependent ubiquitination and activation of LKB1 is essential for cancer cell survival under energy stress.
Lee SW; Li CF; Jin G; Cai Z; Han F; Chan CH; Yang WL; Li BK; Rezaeian AH; Li HY; Huang HY; Lin HK
Mol Cell; 2015 Mar; 57(6):1022-1033. PubMed ID: 25728766
[TBL] [Abstract][Full Text] [Related]
12. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
13. Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma.
Qie S; Yoshida A; Parnham S; Oleinik N; Beeson GC; Beeson CC; Ogretmen B; Bass AJ; Wong KK; Rustgi AK; Diehl JA
Nat Commun; 2019 Mar; 10(1):1296. PubMed ID: 30899002
[TBL] [Abstract][Full Text] [Related]
14. 6-Gingerol Ameliorates Hepatic Steatosis, Inflammation and Oxidative Stress in High-Fat Diet-Fed Mice through Activating LKB1/AMPK Signaling.
Liu Y; Li D; Wang S; Peng Z; Tan Q; He Q; Wang J
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047258
[TBL] [Abstract][Full Text] [Related]
15. Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.
Jung TY; Ryu JE; Jang MM; Lee SY; Jin GR; Kim CW; Lee CY; Kim H; Kim E; Park S; Lee S; Lee C; Kim W; Kim T; Lee SY; Ju BG; Kim HS
Exp Mol Med; 2020 Nov; 52(11):1831-1844. PubMed ID: 33219302
[TBL] [Abstract][Full Text] [Related]
16. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
Zheng L; Zhao Z; Rong L; Xue L; Song Y
J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
[TBL] [Abstract][Full Text] [Related]
17. Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25.
Taylor EB; Ellingson WJ; Lamb JD; Chesser DG; Winder WW
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1055-61. PubMed ID: 15644453
[TBL] [Abstract][Full Text] [Related]
18. Protein Arginine Methyltransferase 5 Promotes Esophageal Squamous Cell Carcinoma Proliferation and Metastasis via LKB1/AMPK/mTOR Signaling Pathway.
Chen YR; Li HN; Zhang LJ; Zhang C; He JG
Front Bioeng Biotechnol; 2021; 9():645375. PubMed ID: 34124017
[No Abstract] [Full Text] [Related]
19. Effects of 3-phosphoglycerate and other metabolites on the activation of AMP-activated protein kinase by LKB1-STRAD-MO25.
Ellingson WJ; Chesser DG; Winder WW
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E400-7. PubMed ID: 16985256
[TBL] [Abstract][Full Text] [Related]
20. Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway.
Fan H; Yu X; Zou Z; Zheng W; Deng X; Guo L; Jiang W; Zhan Q; Lu SH
Carcinogenesis; 2019 Jul; 40(5):669-679. PubMed ID: 30445633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
